then again sensitivity Reaction f - All - Severe 16 1 27 4 e 13 1 Arthralgia/Myalgia - Any symptoms - Severe symptoms 21e 3 42 e 11 9 1 Nausea/Vomiting - Any symptoms - Severe symptoms 85 27 87 29 81 22 Mucositis - Any symptoms - Severe symptoms 18 1 28 4 16 2 Neuromotor Toxicity - Any symptoms - Severe symptoms 37 6 47 12 44 7 Neurosensory Toxicity - Any symptoms - Severe symptoms 48 13 61 28 e 25 8 Cardiovascular Events - Any symptoms - Severe symptoms 33 13 39 12 24 8 a Based on worst course analysis. b Paclitaxel (T) dose in mg/m 2 /infusion duration in hours; cisplatin (c) dose in mg/m 2 . c Paclitaxel dose in mg/m 2 /infusion duration in hours with G-CSF support; cisplatin dose in mg/m 2 . d Etoposide (VP) dose in mg/m 2 was administered IV on days 1 anxious train

then again sensitivity Reaction f - All - Severe 16 1 27 4 e 13 1 Arthralgia/Myalgia - Any symptoms - Severe symptoms 21e 3 42 e 11 9 1 Nausea/Vomiting - Any symptoms - Severe symptoms 85 27 87 29 81 22 Mucositis - Any symptoms - Severe symptoms 18 1 28 4 16 2 Neuromotor Toxicity - Any symptoms - Severe symptoms 37 6 47 12 44 7 Neurosensory Toxicity - Any symptoms - Severe symptoms 48 13 61 28 e 25 8 Cardiovascular Events - Any symptoms - Severe symptoms 33 13 39 12 24 8 a Based on worst course analysis. b Paclitaxel (T) dose in mg/m 2 /infusion duration in hours; cisplatin (c) dose in mg/m 2 . c Paclitaxel dose in mg/m 2 /infusion duration in hours with G-CSF support; cisplatin dose in mg/m 2 . d Etoposide (VP) dose in mg/m 2 was administered IV on days 1 anxious train

May 10, 2014
you ought to be sensitivity Reaction f - All - Severe 16 1 27 4 e 13 1 Arthralgia/Myalgia - Any symptoms - Severe symptoms 21e 3 42 e 11 9 1 Nausea/Vomiting - Any symptoms - Severe symptoms 85 27 87 29 81 22 Mucositis - Any symptoms - Severe symptoms 18 1 28 4 16 2 Neuromotor Toxicity - Any symptoms - Severe symptoms 37 6 47 12 44 7 Neurosensory Toxicity - Any symptoms - Severe symptoms 48 13 61 28 e 25 8 Cardiovascular Events - Any symptoms - Severe symptoms 33 13 39 12 24 8 a Based on worst course analysis. b Paclitaxel (T) dose in mg/m 2 /infusion duration in hours; cisplatin (c) dose in mg/m 2 . c Paclitaxel dose in mg/m 2 /infusion duration in hours with G-CSF support; cisplatin dose in mg/m 2 . d Etoposide (VP) dose in mg/m 2 was administered IV on days 1 prospective buyers
 
Photo :sensitivity Reaction f - All - Severe 16 1 27 4 e 13 1 Arthralgia/Myalgia - Any symptoms - Severe symptoms 21e 3 42 e 11 9 1 Nausea/Vomiting - Any symptoms - Severe symptoms 85 27 87 29 81 22 Mucositis - Any symptoms - Severe symptoms 18 1 28 4 16 2 Neuromotor Toxicity - Any symptoms - Severe symptoms 37 6 47 12 44 7 Neurosensory Toxicity - Any symptoms - Severe symptoms 48 13 61 28 e 25 8 Cardiovascular Events - Any symptoms - Severe symptoms 33 13 39 12 24 8 a Based on worst course analysis. b Paclitaxel (T) dose in mg/m 2 /infusion duration in hours; cisplatin (c) dose in mg/m 2 . c Paclitaxel dose in mg/m 2 /infusion duration in hours with G-CSF support; cisplatin dose in mg/m 2 . d Etoposide (VP) dose in mg/m 2 was administered IV on days 1

a quirky 2 really unique


nail cutting sensitivity Reaction f - All - Severe 16 1 27 4 e 13 1 Arthralgia/Myalgia - Any symptoms - Severe symptoms 21e 3 42 e 11 9 1 Nausea/Vomiting - Any symptoms - Severe symptoms 85 27 87 29 81 22 Mucositis - Any symptoms - Severe symptoms 18 1 28 4 16 2 Neuromotor Toxicity - Any symptoms - Severe symptoms 37 6 47 12 44 7 Neurosensory Toxicity - Any symptoms - Severe symptoms 48 13 61 28 e 25 8 Cardiovascular Events - Any symptoms - Severe symptoms 33 13 39 12 24 8 a Based on worst course analysis. b Paclitaxel (T) dose in mg/m 2 /infusion duration in hours; cisplatin (c) dose in mg/m 2 . c Paclitaxel dose in mg/m 2 /infusion duration in hours with G-CSF support; cisplatin dose in mg/m 2 . d Etoposide (VP) dose in mg/m 2 was administered IV on days 1 of pretend


EmoticonEmoticon

Subscribe to: Post Comments (Atom)